Unlearn harnesses artificial intelligence to produce digital twins of participants in clinical trials, optimizing the development process and supporting informed decision-making. Their innovative platform forecasts outcomes for each participant right at the start of a clinical study, accurately predicting all clinical results at various future time points. By generating these digital representations of patients, Unlearn offers a cutting-edge, user-friendly interface that reduces trial failures, lowers expenses, and accelerates project timelines.
Research & Insights

.png)

